Results 141 to 150 of about 53,966 (218)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2. [PDF]

Cureus, 2023
Gonzalez Martinez OG, Ayala Rodríguez SC, Pappaterra-Rodriguez M, Requejo-Figueroa G, Oliver AL.   +4 more
europepmc   +1 more source

Supply Chain Volatility of Repackaged Intravitreal Bevacizumab: A Survey of the American Society of Retina Specialists. [PDF]

J Vitreoretin Dis
Al-Khersan H, Busquets M, Ghorayeb G, Gong D, Kolomeyer A, Leung EH, Niles P, Patel NA, Shah AR, Wykoff CC, Blim J, Jumper JM, Lai MM.   +12 more
europepmc   +1 more source

Design and characterization of intravitreal bevacizumab-loaded PLGA nanoparticles: pharmacokinetic and biodistribution impact. [PDF]

Drug Deliv Transl Res
Varela-Fernández R, García-Otero X, Cuartero-Martínez A, Gómez-Lado N, González-Barcia M, Mondelo-García C, Aguiar P, Fernández-Ferreiro A, Otero-Espinar F.   +8 more
europepmc   +1 more source

Effect of intravitreal Bevacizumab on coagulation profile of patients with diabetic retinopathy. [PDF]

Pak J Med Sci
Khalid I, Malik TG, Tariq H, Sajid U.
europepmc   +1 more source

Retinal Vascularization Timeline following Intravitreal Bevacizumab Injection in Infants with Retinopathy of Prematurity: A Retrospective Study. [PDF]

J Curr Ophthalmol
Shoeibi N, Mousavi M, Abrishami M, Hosseini SM, Ansari-Astaneh MR, Abrishami M, Zamani G, Bakhtiari E, Gharib B, Neghabi F, Shariati MM.   +10 more
europepmc   +1 more source

Short-Term Follow-Up Study on the Efficacy and Safety of Intravitreal Bevacizumab for Macular Edema Secondary to Retinal Venous Occlusions. [PDF]

Cureus
Kandukuri R, Lakshmi S, Dinesh Kanth V.
europepmc   +1 more source

Delayed-Onset Glaucoma Following Intravitreal Bevacizumab in a Preterm Infant with Retinopathy of Prematurity: A Case Report. [PDF]

Korean J Ophthalmol
Jang HJ, Sung MS, Park SW, Heo H.
europepmc   +1 more source

Outcomes of Combined Therapy With Focal Laser and Intravitreal Bevacizumab for Retinal Arterial Macroaneurysm: A Case Series. [PDF]

Cureus
Jemelian A, Enghelberg M.
europepmc   +1 more source

Interferon alpha-2b addition to intravitreal bevacizumab for diabetic macular edema: a randomized controlled trial. [PDF]

Int J Retina Vitreous
Karimi S, Nouri M, Mansouri AR, Hassanzadeh G, Nouri H, Rikani SM, Abtahi SH.   +6 more
europepmc   +1 more source

Off-label use of intravitreal bevacizumab: A global conundrum. [PDF]

Indian J Ophthalmol
Singh S, Saxena S, Akduman L, Meyer CH.
europepmc   +1 more source